Exploration funding expands
Equity and other net financing lifted cash while exploration cash expenditure was substantial.
Eagle Mountain Mining’s FY2021-FY2025 record moves from heavily funded exploration to a smaller cash base and a major Oracle Ridge impairment. This review separates restated accounts, real cash flows and the decision to relinquish core mineral rights.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Consolidated balance.
Negative total equity.
Includes asset impairment.
Expense; not cash paid that year.
Exploration at Oracle Ridge and Silver Mountain was the principal activity. In FY2025 the company chose not to extend the Oracle Ridge mineral-rights option, ending the surface lease while retaining surrounding Wedgetail claims.
This is not simply a spending slowdown: the change removed the mineral-rights basis for the Oracle Ridge resource and led to a substantial asset impairment.
Equity and other net financing lifted cash while exploration cash expenditure was substantial.
Restated comparative accounts show the largest operating outflow in this five-year series, alongside substantial funding.
An updated valuation corrected earlier overstatement of the conversion-right liability; prior balances were restated.
Operating use fell and net financing modestly rebuilt cash.
The option was not extended; acquisition costs were impaired and the surrounding claims retained as Wedgetail.
The FY2025 balance sheet carries negative equity and material borrowings. The A$3m related-party loan converted through entitlement-offer sub-underwriting; it should not be described as A$3m of additional cash funding.
A$ million
AI-generated presentation · values from Liquidity and consolidated equity; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Liquidity and consolidated equity; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and equivalents | 9.119 | 11.074 | 2.237 | 3.117 | 1.113 |
| Total equity / (net liabilities) | 8.423 | 11.796 | 4.544 | 3.197 | (6.323) |
FY2021 and FY2022 equity use restated opening/comparative figures from FY2023. FY2025 is net liabilities, not positive equity.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2025 operating cash use declined, but the statutory loss rose because it includes impairment. The cash-flow statement remains the basis for financing totals, rather than the face value of new shares.
A$ million
AI-generated presentation · values from Restated-comparative and recent losses; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Cash use and funding across five years; no missing values plotted as zero.
A$ million
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Group loss after tax, continuing operations | (30.748) | (13.661) | (6.445) | (15.256) |
| Net operating cash flow | (29.229) | (13.075) | (5.090) | (3.720) |
FY2022 is restated for the convertible-note valuation correction. A duplicated changes-in-equity extraction mislabels FY2022/FY2023 losses; the income statement and narrative establish the selected years.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 |
|---|---|
| Group loss after tax | (21.070) |
A$21.070m is the original FY2021 result, before the subsequent conversion-right valuation restatement. It is not plotted as a fully restated five-year earnings series.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net operating cash flow | (9.908) | (29.229) | (13.075) | (5.090) | (3.720) |
| Net investing cash flow | (0.267) | (0.503) | (3.536) | 0.104 | (0.244) |
| Net financing cash flow | 18.709 | 30.930 | 7.677 | 5.869 | 1.947 |
Ongoing exploration is included in operating cash. FY2024 investing is a net inflow despite legacy row wording. Loan conversion to equity is not counted as fresh cash.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The auditor identified material uncertainty relating to going concern. Year-end cash was below current liabilities, while the board maintained the going-concern basis; those are different statements, not an all-clear on funding.
The full impairment in profit and loss includes the Oracle Ridge acquisition-cost write-off. A smaller exploration-asset component in a separate audit narrative is not added to it as another expense.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.